Table 3:

Summary of secondary outcomes and sensitivity analyses

	Cohort characteristics		Measures of Association
			Cephalosporins		Penicillins		Carbapenems
Outcome	Exposure Window	T Cell Content	aOR/subHR (95% CI)	p value	aOR/subHR (95% CI)	p value	aOR/subHR (95% a)	p value
Grade II-IV aGVHD	Conditioning to day +7	Any	1.05 (0.83-1.32)	0.710	1.24 (0.93-1.66)	0.140	1.24 (1.02-1.51)	0.035
Time to grade II-IV aGVHD	Conditioning to GHVD onset	Any	1.09 (0.73-1.63)	0.660	1.02 (0.67-1.54)	0.940	1.31 (0.99-1.72)	0.059
Time to grade III-IV aGVHD	Conditioning to GHVD onset	Any	0.90 (0.55-1.49)	0.700	1.52 (0.87-2.66)	0.140	1.77 (1.25-2.52)	0.001
Time to grade II-IV lower GI aGVHD	Conditionng to GHVD onset	Any	0.82 (0.57-1.17)	0.267	1.25 (0.81-1.95)	0.316	1.27 (0.91-1.78)	0.163
Grade II-IV aGVHD	Conditioning to day +7	T-replete	1.20 (0.90-1.60)	0.220	1.41 (0.99-2.01)	0.054	1.33 (1.00-1.76)	0.046
Grade II-IV aGVHD	Conditioning to day 0	Any	1.01 (0.82-1.23)	0.590	1.10 (0.76-1.58)	0.620	1.45 (1.05-2.02)	0.026
Grade II-IV aGVHD	Day 0 to day +7	Any	1.07 (0.85-1.35)	0.590	1.12 0.84-1.49	0.450	1.17 (0.96-1.42)	0.120

aOR adjusted Odds Ratio; subHR sub Hazard Ratio; aGVHD acute Graft Versus Host Disease; GI Gastrointestinal